Lv7
3970 积分 2023-03-06 加入
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
8天前
已完结
How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions
25天前
已完结
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses
1个月前
已完结
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
1个月前
已完结
Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia
3个月前
已完结
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes
3个月前
已完结
Dynamic evolution of venetoclax resistance in acute myeloid leukemia unveiled by longitudinal single-cell RNA-seq
3个月前
已完结
Deciphering human macrophage development at single-cell resolution
3个月前
已完结
ZMYM2‐FLT3 Fusion Gene: Implications for Chromosomal Instability and Proliferation in Myeloid/Lymphoid Neoplasms
4个月前
已完结
Resolving inter- and intra-patient heterogeneity inNPM1-mutated AML at single-cell resolution
5个月前
已完结
皖公网安备34019202002308
